Task order no.5. Synthesis and distribution of opioid and related peptides. Period of performance: 02/15/2025-02/14/2026. N01DA-22-8963
Ended Awarded Last action
- Contract number
- 75N95025F00001
- Awardee
-
Polypeptide Laboratories San Diego, LLC UEI KULKXN9J6PF9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $595,094
Award facts
- Opportunity
-
- TORFP75N95025F00001 Solicitation number
- Contract value 100% obligated
- $595,094.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92126, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $595,094 |
About this award
This is a cost-plus-fixed-fee task order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The contract, valued at $595,094.00, is for the synthesis and distribution of opioid and related peptides over a one-year period of performance from February 15, 2025, to February 14, 2026. This task order is part of a larger $2,781,317 Indefinite Delivery Contract (IDC) that Polypeptide Labs holds with NIDA for similar peptide synthesis and distribution services, running from February 15, 2022, to February 14, 2027. The contract does not have a set-aside designation, indicating Polypeptide Labs' competitive capabilities in meeting NIDA's specialized research requirements. As a manufacturer of goods with expertise in peptide synthesis, Polypeptide Labs has consistently provided critical services to NIH agencies, including NIDA, the National Cancer Institute, and the National Institute of Child Health and Human Development, for biomedical research initiatives.
Quick answers
Who was awarded contract 75N95025F00001?
75N95025F00001 was awarded to Polypeptide Laboratories San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on February 15, 2025.
How much is contract 75N95025F00001 worth?
The government has obligated $595,094 on 75N95025F00001.
Is contract 75N95025F00001 an order under another contract?
Yes. 75N95025F00001 is a delivery order under 75N95022D00005, an indefinite delivery contract.
Was contract 75N95025F00001 competed?
The extent of competition for 75N95025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award